Viatris launches $36.50-a-share tender offer for Pacira BioSciences

Viatris commenced a cash tender offer, through its subsidiary Peach Purchaser Sub, for all outstanding shares of Pacira BioSciences at $36.50 per share. The offer follows an October 8 merger agreement. After the tender closes, Pacira will merge with the subsidiary and become wholly owned by Viatris.

Why it matters: Launching the tender moves the pending pharma deal into its final stage.